Health
Medical
Biopharmaceutical

Aptinyx

$3.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-4.03%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Aptinyx and other stocks, options, ETFs, and crypto commission-free!

About APTX

Aptinyx Inc. Common Stock, also called Aptinyx, is a clinical stage biopharmaceutical company. Read More It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.

Employees
63
Headquarters
Evanston, Illinois
Founded
2015
Market Cap
124.39M
Price-Earnings Ratio
Dividend Yield
Average Volume
204.28K
High Today
$3.76
Low Today
$3.51
Open Price
$3.70
Volume
115.83K
52 Week High
$32.25
52 Week Low
$2.88

Collections

Health
Medical
Biopharmaceutical
Pharmaceutical
2018 IPO
US
North America

APTX Earnings

-$0.52
-$0.49
-$0.45
-$0.42
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.52 per share
Actual
Expected Jul 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.